Skin cancer Board decisions

The Board has determined that the veteran's death was caused by metastatic malignant melanoma, which is more likely than not a result of extensive military sun exposure during service. With resolution of reasonable doubt in favor of the appellant, the claim for service connection for the cause of the veteran's death is granted.

The Board has granted the appellant's claim for dependency and indemnity compensation based on service connection for the cause of the veteran's death, which was caused by metastatic melanoma that originated from sun exposure during his military service.

The Board has denied the veteran's claims for service connection for tinnitus and skin cancer, finding that there is no evidence linking these conditions to his military service.

The Board denied the veteran's claims for service connection for COPD and skin cancer, finding that COPD was not incurred in or aggravated by active duty service and that skin cancer is not related to service. The claim for hearing loss of the right ear remains pending.

The veteran's appeal is being remanded for further development and readjudication of her claims, including the evaluation of her foot disability and the recovery of severance pay.

The Board has determined that the veteran's cause of death and his claim for melanoma of the right eye with liver metastasis are not service-connected, thus denying both claims.

The Board has determined that the veteran's death was not caused by a service-connected disability, and thus denied the claim for service connection for the cause of the veteran's death.

The veteran's claims for service connection were denied across the board. The Board found no evidence of current conditions or a nexus to service, including Agent Orange exposure.

The Board denied service connection for dermatoheliosis, actinic keratosis, solar lentigo and squamous cell carcinoma. The veteran's skin disorders were not linked to his military service.

The Board has denied the veteran's claims for service connection for skin cancer and PTSD as there is no evidence of a current disability related to active military service, and the stressors claimed for PTSD have not been verified.

The Board denied the veteran's claims for service connection for skin cancer and prostate cancer, finding that there was no evidence to support a link between his exposure to ionizing radiation in service and his current conditions.

The veteran's appeal has been dismissed due to his death.

The VA determined that the veteran's skin cancer was not related to his military service, including exposure to ionizing radiation.

The Board denied service connection for residuals of pneumonia and skin cancer. Service connection was not granted for residuals of pneumonia due to lack of evidence linking the condition to service, including inservice pneumonia. Service connection was also not granted for skin cancer as there is no current diagnosis or evidence linking it to service.

The veteran's claimed conditions are not shown to be related to his military service or Agent Orange exposure.

The veteran's appeal is being remanded due to the need for additional records and further review.

The Board has determined that the veteran's malignant melanoma is not related to his service, including any potential herbicide exposure in Vietnam. As a result, the claim for service connection for malignant melanoma is denied.

The veteran's claim for service connection for tinnitus has been reopened and granted. The claim for skin cancer was denied as there is no evidence of a current disability. The claim for an initial compensable rating for bilateral hearing loss disability remains unchanged.

The Board has determined that the veteran does not have a current diagnosis of an anxiety disorder or melanoma, and there is no evidence linking these conditions to service. The claim for tinnitus was remanded due to procedural issues.

The veteran seeks service connection for a condition that resulted in an amputation, including exposure to ionizing radiation. The case is being remanded due to the need for additional development regarding potential exposure and dose estimates.